Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anbio Biotechnology Class A ( (NNNN) ) has issued an announcement.
On February 11, 2026, Anbio Biotechnology’s board and audit committee dismissed HTL International, LLC as the company’s independent registered public accounting firm after concluding that a different auditor would be better positioned to meet its reporting timetable for the fiscal year ended December 31, 2025. The company stated there were no disagreements with HTL International over accounting principles, financial disclosures, or audit procedures during the engagement, and the outgoing firm later confirmed its agreement with Anbio’s characterization of the circumstances.
On the same date, Anbio’s board and audit committee approved and ratified the appointment of GGF CPA LTD as the new independent registered public accounting firm to audit the company’s financial statements, including the upcoming Annual Report on Form 20-F for 2025. Anbio also disclosed that it had not previously consulted GGF CPA LTD on accounting treatments, audit opinions, or any matters involving disagreements or reportable events, suggesting the change is driven primarily by capacity and timing considerations rather than underlying financial reporting disputes.
More about Anbio Biotechnology Class A
Anbio Biotechnology, a foreign private issuer listed in the United States, operates in the biotechnology sector and files its reports with the U.S. Securities and Exchange Commission under Form 20-F. The company is headquartered in Frankfurt am Main, Germany, and is overseen by a board of directors and an audit committee responsible for financial reporting and compliance.
Average Trading Volume: 51,546
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.48B
Learn more about NNNN stock on TipRanks’ Stock Analysis page.